Talk:Palbociclib

This is the talk page for discussing improvements to the Palbociclib article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Start‑class Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Start	This article has been given a rating which conflicts with the project-independent quality rating in the banner shell. Please resolve this conflict if possible.
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Palbociclib.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Need to clarify the HER2-negative

Is approval only for ER+ if patient/tumour also HER2-negative ? - Rod57 (talk) 04:22, 30 December 2015 (UTC)[reply]

What next - PALOMA-2 - EU

When is PALOMA-2 due to report data ? Is it needed for an EU application ? When is an EU application expected ? - Rod57 (talk) 18:02, 30 December 2015 (UTC)[reply]

History - Chemistry

How was this molecule found ? Is it a derivative or analogue of a natural molecule ? - Rod57 (talk) 19:17, 30 December 2015 (UTC) To partially answer your question, a sustained medicinal chemistry effort was made to identify selective Cdk4/6 inhibitors. A description of the work conducted over many years can be found in the following references: https://pubs.acs.org/doi/abs/10.1021/jm049355%2B Pyrido[2,3-d]pyrimidin-7-ones as Specific Inhibitors of Cyclin-Dependent Kinase 4, Scott N. VanderWel, Patricia J. Harvey, Dennis J. McNamara, et al, Adapted with permission from the Journal of Medicinal Chemistry, American Chemical Society, Apr 1, 2005, Copyright © 2005, American Chemical Society. (full article is paywall protected). Additional information may be available in the references contained in the footnotes. Continued synthetic work prepared and identified PD 0332991 which would later be named Palbociclib, the Cdk4-inhibiting component in (IBRANCE®, Pfizer Inc.). Structural similarity of the earlier leads to PD 0332991 can be seen: https://pubs.acs.org/doi/10.1021/jm049354h Discovery of a Potent and Selective Inhibitor of Cyclin-Dependent Kinase 4/6, Peter L. Toogood, Patricia J. Harvey, Joseph T. Repine, et al., Adapted with permission from the Journal of Medicinal Chemistry, American Chemical Society, Apr 1, 2005, Copyright © 2005, American Chemical Society. (full article is paywall protected).JTR26 (talk) 15:32, 21 May 2018 (UTC)[reply]

How is it administered

How is it administered (oral?, IV?, SC?). How often ? - Rod57 (talk) 17:36, 25 November 2016 (UTC)[reply]

Theory/motivation

Why is it added to other therapies ? Is it to kill cancer cells, avoid resistance, or reduce side-effects ? - Rod57 (talk) 17:40, 25 November 2016 (UTC)[reply]